353 related articles for article (PubMed ID: 20206839)
21. Late diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Müssig K; Kaltenbach S; Maser-Gluth C; Hartmann MF; Wudy SA; Horger M; Gallwitz B; Raue F; Häring HU; Schulze E
Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):208-14. PubMed ID: 16705555
[TBL] [Abstract][Full Text] [Related]
22. A rare CYP 21 mutation (p.E431K) induced deactivation of CYP 21A2 and resulted in congenital adrenal hyperplasia.
Kawashima Y; Usui T; Fujimoto M; Miyahara N; Nishimura R; Hanaki K; Kanzaki S
Endocr J; 2015; 62(1):101-6. PubMed ID: 25319875
[TBL] [Abstract][Full Text] [Related]
23. [Determination of serum steroids in monitoring therapy of congenital adrenal hyperplasia].
Xiao HW; Ma HM; Su Z; Du ML; Li YH; Chen HS; Chen QL
Zhonghua Er Ke Za Zhi; 2012 Apr; 50(4):301-7. PubMed ID: 22801236
[TBL] [Abstract][Full Text] [Related]
24. [Usefulness of molecular analysis in the differential diagnosis of congenital 21-hidroxylase deficiency detected in neonatal screening].
Soriano Guillén L; Velázquez De Cuellar Paracchi M; Ezquieta B
Med Clin (Barc); 2011 Mar; 136(7):313-4. PubMed ID: 19766262
[No Abstract] [Full Text] [Related]
25. [CYP21 gene point mutations study in 21-hydroxylase deficiency patients].
Liao XY; Zhang YF; Gu XF
Zhonghua Er Ke Za Zhi; 2003 Sep; 41(9):670-4. PubMed ID: 14733808
[TBL] [Abstract][Full Text] [Related]
26. Rare combination of simple virilizing form of 21-hydroxylase deficiency, Graves' disease and 47, XXX in a woman: A case report.
Liang D; Han M; Xu L; Ren Y; Zhang Y; Yin J; Yang J; Liu Y
Medicine (Baltimore); 2022 Oct; 101(43):e31443. PubMed ID: 36316845
[TBL] [Abstract][Full Text] [Related]
27. 17-Hydroxyprogesterone in children, adolescents and adults.
Honour JW
Ann Clin Biochem; 2014 Jul; 51(Pt 4):424-40. PubMed ID: 24711560
[TBL] [Abstract][Full Text] [Related]
28. ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism.
Siegel SF; Finegold DN; Lanes R; Lee PA
N Engl J Med; 1990 Sep; 323(13):849-54. PubMed ID: 2168515
[TBL] [Abstract][Full Text] [Related]
29. Hyperandrogenism in carriers of CYP21 mutations: the role of genotype.
Admoni O; Israel S; Lavi I; Gur M; Tenenbaum-Rakover Y
Clin Endocrinol (Oxf); 2006 Jun; 64(6):645-51. PubMed ID: 16712666
[TBL] [Abstract][Full Text] [Related]
30. Influence of different genotypes on 17-hydroxyprogesterone levels in patients with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Bachega TA; Billerbeck AE; Marcondes JA; Madureira G; Arnhold IJ; Mendonca BB
Clin Endocrinol (Oxf); 2000 May; 52(5):601-7. PubMed ID: 10792340
[TBL] [Abstract][Full Text] [Related]
31. High frequency of non-classical congenital adrenal hyperplasia form among children with persistently elevated levels of 17-hydroxyprogesterone after newborn screening.
Castro PS; Rassi TO; Araujo RF; Pezzuti IL; Rodrigues AS; Bachega TASS; Silva IN
J Pediatr Endocrinol Metab; 2019 May; 32(5):499-504. PubMed ID: 31028712
[TBL] [Abstract][Full Text] [Related]
32. [Detection of CYP21A2 gene mutations and the differences in the levels of hormones in patients with 21-hydroxylase deficiency].
Gao YJ; Yu BQ; Lu L; Wu XY; Mao JF; Wang X; Tong AL; Chen S; Nie M
Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(8):586-592. PubMed ID: 32164112
[No Abstract] [Full Text] [Related]
33. Genetic analysis and novel variation identification in Chinese patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Xia Y; Shi P; Gao S; Liu N; Zhang H; Kong X
J Steroid Biochem Mol Biol; 2022 Sep; 222():106156. PubMed ID: 35882282
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of CYP21A2 gene mutations in two families with 21-hydroxylase deficiency].
Zheng R; Zhao Z; Wang Y; Yuan H; Wang S; Su Y; Ma Y; Hu Z; Tian R; Wang L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Jun; 31(3):289-93. PubMed ID: 24928004
[TBL] [Abstract][Full Text] [Related]
35. Clinical, biochemical, and genetic features of non-classical 21-hydroxylase deficiency in Japanese children.
Kashimada K; Ishii T; Nagasaki K; Ono M; Tajima T; Yokota I; Hasegawa Y
Endocr J; 2015; 62(3):277-82. PubMed ID: 25736066
[TBL] [Abstract][Full Text] [Related]
36. Refining hormonal diagnosis of type II 3beta-hydroxysteroid dehydrogenase deficiency in patients with premature pubarche and hirsutism based on HSD3B2 genotyping.
Mermejo LM; Elias LL; Marui S; Moreira AC; Mendonca BB; de Castro M
J Clin Endocrinol Metab; 2005 Mar; 90(3):1287-93. PubMed ID: 15585552
[TBL] [Abstract][Full Text] [Related]
37. Genetics of adrenal steroid 21-hydroxylase deficiency.
New MI; Speiser PW
Endocr Rev; 1986 Aug; 7(3):331-49. PubMed ID: 3527688
[TBL] [Abstract][Full Text] [Related]
38. Adrenocortical adenoma associated with inadequately treated congenital adrenal hyperplasia.
Kurtoğlu S; Atabek ME; Keskin M; Patiroglu TE
J Pediatr Endocrinol Metab; 2003 Dec; 16(9):1311-4. PubMed ID: 14714757
[TBL] [Abstract][Full Text] [Related]
39. Congenital adrenal hyperplasia in adolescents: diagnosis and management.
Lin-Su K; Nimkarn S; New MI
Ann N Y Acad Sci; 2008; 1135():95-8. PubMed ID: 18574213
[TBL] [Abstract][Full Text] [Related]
40. A pilot study on newborn screening for congenital adrenal hyperplasia in Beijing.
Gong LF; Gao X; Yang N; Zhao JQ; Yang HH; Kong YY
J Pediatr Endocrinol Metab; 2019 Mar; 32(3):253-258. PubMed ID: 30817302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
